1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Inotiv, Inc.
  6. News
  7. Summary
    NOTV   US45783Q1004

INOTIV, INC.

(NOTV)
  Report
Real-time Estimate Cboe BZX  -  10:08 2022-08-10 am EDT
20.19 USD   +5.05%
08/09Over 4,000 beagles destined for drug experiments finding new homes
RE
08/01Inotiv, Inc. to Report Third Quarter Fiscal 2022 Financial Results and Host Conference Call on Wednesday, August 10, 2022
GL
08/01Inotiv, Inc. to Report Third Quarter Fiscal 2022 Financial Results and Host Conference Call on Wednesday, August 10, 2022
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about INOTIV, INC.
08/01Inotiv, Inc. to Report Third Quarter Fiscal 2022 Financial Results and Host Conference ..
GL
08/01Inotiv, Inc. to Report Third Quarter Fiscal 2022 Financial Results and Host Conference ..
GL
07/26Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays..
GL
07/26Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays..
AQ
07/26Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays..
CI
07/25Inotiv, Inc. Decides to Close Two of its Facilities, a Purpose-Bred Canine Facility in ..
CI
07/19Inotiv Shares Keep Rising, Up 15%
DJ
07/18Inotiv Shares Rise 18% After Settlement With Justice Dept, USDA
DJ
07/18Inotiv Says Envigo Settles Administrative Complaints With Departments of Justice and Ag..
MT
07/18Envigo Reaches Agreement with the U.S. Department of Justice and the U.S. Department of..
GL
07/18Envigo Reaches Agreement with the U.S. Department of Justice and the U.S. Department of..
AQ
07/08Inotiv Completes Acquisition of Protypia
MT
07/07Inotiv, Inc. Expands Protein/Peptide Bioanalytical Capabilities with Acquisition of Pro..
GL
07/07Inotiv, Inc. acquired Protypia, Inc. for $11 million.
CI
06/24Inotiv, Inc. Announces Retirement of James Harkness as Chief Operating Officer, Effecti..
CI
More most relevant news
All news about INOTIV, INC.
08/09Over 4,000 beagles destined for drug experiments finding new homes
RE
08/01Inotiv, Inc. to Report Third Quarter Fiscal 2022 Financial Results and Host Conference ..
GL
08/01Inotiv, Inc. to Report Third Quarter Fiscal 2022 Financial Results and Host Conference ..
GL
07/26Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays..
GL
07/26Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays..
AQ
07/26Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays..
CI
07/25INOTIV, INC. Costs Associated with Exit or Disposal Activities, Material Impairments, ..
AQ
07/25Inotiv, Inc. Decides to Close Two of its Facilities, a Purpose-Bred Canine Facility in ..
CI
07/20INOTIV, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
07/19Inotiv Shares Keep Rising, Up 15%
DJ
More news
News in other languages on INOTIV, INC.
07/26Inotiv, Inc. Inotiv continue d'élargir son offre en matière de toxicologie génétique en..
07/25Inotiv, Inc. décide de fermer deux de ses installations, une installation pour chiens d..
07/18Inotiv dit qu'Envigo règle les plaintes administratives avec les départements de la jus..
07/07INOTIV, INC. (NASDAQCM : NOTV) a acquis Protypia, Inc. pour 11 millions de dollars.
06/24Inotiv, Inc. annonce le départ à la retraite de James Harkness en tant que directeur de..
06/22Inotiv, Inc. Nomme Glenn Washer au poste de président de groupe, évaluation de la sécur..
05/23Inotiv déclare que le ministère américain de la Justice a déposé une plainte pour des v..
05/13MISE À JOUR SECTORIELLE : Les actions du secteur de la santé ajoutent du soutien dans la p..
05/13MISE À JOUR SECTORIELLE : Les actions du secteur de la santé affichent des gains modestes ..
05/13Le deuxième trimestre d'Inotiv est supérieur aux estimations de la Bourse ; le chiffre ..
More news
Analyst Recommendations on INOTIV, INC.
06/14Lake Street Adjusts Inotiv's Price Target to $50 from $75, Maintains Buy Rating
MT
02/02Craig-Hallum Adjusts Inotiv's Price Target to $64 From $57, Reiterates Buy Rating
MT
01/31Lake Street Initiates Inotiv at Buy, Sets Price Target to $60
MT
2021INOTIV : Craig-Hallum Starts Inotiv at Buy with $45 Price Target
MT
2020BIOANALYTICAL : Colliers Securities Starts Bioanalytical Systems at Buy With $17 Price Tar..
MT
More recommendations
Press releases
08/01Inotiv, Inc. to Report Third Quarter Fiscal 2022 Financial Results and Host Conference ..
GL
08/01Inotiv, Inc. to Report Third Quarter Fiscal 2022 Financial Results and Host Conference ..
GL
07/26Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays..
GL
07/26Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays..
AQ
07/25INOTIV, INC. Costs Associated with Exit or Disposal Activities, Material Impairments, ..
AQ
More press releases
Upcoming event on INOTIV, INC.